The fragile histidine triad gene: A molecular link between cigarette smoking and cervical cancer

Clinical Cancer Research

Volumn 11, Issue 16, 2005, Pages 5756-5763

  Holschneider, Christine H ^a,b,c   Baldwin, Rae Lynn ^b   Tumber, Kiran ^b   Aoyama, Chisa ^c   Karlan, Beth Y ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; GENE PRODUCT; MICROSATELLITE DNA;

ADULT; ARTICLE; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ISOLATION; FEMALE; FRAGILE HISTIDINE TRIAD GENE; GENE DELETION; GENE LOCUS; HEMIZYGOSITY; HEMIZYGOUS DELETION; HOMOZYGOSITY; HOMOZYGOUS DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

ACID ANHYDRIDE HYDROLASES; ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE DELETION; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 23844537479     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0234     Document Type: Article

References (49)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
2. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
3. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12:485-90.
4. American Cancer Society. Cancer facts and figures 2004. Available at: http://www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf. Retrieved December 21, 2004.
5. Winckelstein W, Jr. Smoking and cervical cancer-current status: a review. Am J Epidemiol 1990;131:945-57.
6. Haverkos HW, Soon G, Steckley SL, Pickworth W. Cigarette smoking and cervical cancer: Part I. A meta-analysis. Biomed Pharmacother 2003;57:67-77.
7. Hellberg D, Nilsson S, Haley NJ, Hoffman D, Wynder E. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 1988;158:910-3.
8. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997;89:868-73.
9. Sasson IM, Haley NJ, Hoffmann D, Wynder EL, Hellberg D, Nilsson S. Cigarette smoking and neoplasia of the uterine cervix: Smoke constituents in cervical mucus. N Engl J Med 1985;312:315-6.
10. Melikian AA, Sun P, Prokopczyk B, et al. Identification of benzo[a]pyrene metabolites in cervical mucous and DNA adducts in cervical tissue in humans by gas chromatography-mass spectrometry. Cancer Lett 1999;146:127-34.
11. Sozzi G, Sard L, De Gregorio L, et al. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res 1997;57:2121-3.
12. Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT. Chromosome 3p14 alterations in lung cancer: Evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res 1998;58:1804-7.
13. Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 2004;25:2165-71.
14. Huebner K, Croce CM. Cancer and the FRA3B/FHIT fragile locus: It's a HIT. Br J Cancer 2003;88:1501-6.
15. Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996:84:587-97.
16. Larson AA, Kern S, Curtiss S, Gordon R, Cavenee WK, Hampton GM. High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res 1997;57:4082-90.
17. Wistuba II, Montellano FD, Milchgrub S, et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 1997;57:3154-8.
18. Kersemaekers AM, Hermans J, Fleuren GJ, van de Vijver MJ. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer 1998;77:192-200.
19. Fong KM, Biesterveld EJ, Virmani A, et al. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHITcDNA splicing aberrations. Cancer Res 1997;57:2256-67.
20. UCSC Genome Bioinformatics. UCSC Human Gene Sorter: FHITon Human April 2003 Assembly. Available at: http://www.genome.ucsc.edu. Retrieved August 18, 2003 and December 29, 2004.
21. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: Direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 1996;5:187-95.
22. Backer NA, Thorland EC, Denison SR, Phillips LA, Smith DI. Evidence that instability within the FRA3B region extends four megabases. Oncogene 2002;21:8713-22.
23. Thorland EC, Myers SL, Gostout BS, Smith DI. Common fragile sites are preferential targets for HPV 16 integration in cervical tumors. Oncogene 2003;22:1225-37.
24. Corbin S, Neilly ME, Espinosa R III, Davis EM, McKeithan TW, Le Beau MM. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3P14.2 in tumors. Cancer Res 2002;62:3477-84.
25. Greenspan DL, Connolly DC, Wu R, et al. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 1997;57:4692-8.
26. Muller CY, O'Boyle JD, Fong KM, et al. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: Association with human papillomavirus type. J Natl Cancer Inst 1998;90:433-9.
27. Nakagawa S, Yoshikawa H, Kimura M, et al. A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix. Br J Cancer 1999;79:589-94.
28. Siprashvili Z, Sozzi G, Barnes LD, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A 1997;94:13771-6.
29. Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res 1999;59:3333-9.
30. Sard L, Accornero P, Tornielli S, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci U S A 1999;96:8489-92.
31. Roz L, Andriani F, Ferreira CG, Giaccone G, Sozzi G. The apoptotic pathway triggered by the FHIT protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression. Oncogene 2004;23:9102-10.
32. Fong LYY, Fidanza V, Zanesi N, et al. Muir-Torre-like syndrome in FHIT deficient mice. Proc Natl Acad Sci U S A 2000;97:4742-7.
33. Dumon KR, Ishii H, Fong LYY, et al. FHIT gene therapy prevents tumor development in FHIT deficient mice. Proc Natl Acad Sci U S A 2001;98:3346-51.
34. Fujishita T, Doi Y, Sonoshita M, et al. Development of spontaneous tumours and intestinal lesions in FHIT gene knockout mice. Br J Cancer 2004;91:1571-4.
35. Huebner K, Druck T, Siprashvili Z, Croce CM, Kovatich A, McCue PA. The role of deletions at the FRA3B/FHIT locus in carcinogenesis. Recent Results Cancer Res 1998;154:200-15.
36. Sozzi G, Pastorino U, Moiraghi L, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 1998;58:5032-7.
37. Zochbauer-Muller S, Wistuba II, Minna JD, Gazdar AF. Fragile histidine triad (FHIT) gene abnormalities in lung cancer. Clin Lung Cancer 2000;2:141-5.
38. Zochbauer-Muller S, Fong KM, Maitra A, et al. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 2001;61:3581-5.
39. Virmani AK, Muller C, Rathi A, Zochbauer-Muller S, Mathis M, Gazdar AF, Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001;7:584-9.
40. Le Beau MM, Drabkin H, Glover TW, et al. An FHIT tumor suppressor gene? Genes Chromosomes Cancer 1998;21:281-9.
41. Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clin Oncol 1999;17:1618-24.
42. Aveyard JS, Knowles MA. Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification. J Mol Diagn 2004;6:356-65.
43. Mihaila D, Gutierrez JA, Rosenblum ML, Newsham IF, Bogler O, Rempel SA. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Clin Cancer Res 2003;9:4435-42.
44. Guo Z, Wu F, Asplund A, et al. Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence of polyclonal origin of cervical squamous carcinoma. Mod Pathol 2001;14:54-61.
45. Stein CK, Glover TW, Palmer JL, Glisson BS. Direct correlation between FRA3B expression and cigarette smoking. Genes Chromosomes Cancer 2002;34:333-40.
46. Ferber MJ, Thorland EC, Brink AA, et al. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 2003;22:7233-42.
47. Mimori K, Druck T, Inoue H, et al. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci U S A 1999;96:7456-61.
48. Hopman AHN, Smedts F, Dignef W, et al. Transition of high-grade intraepithelial neoplasia to microinvasive carcinoma is characterized by integration of HPV-16/18 and numerical chromosome abnormalities. J Pathol 2004;202:23-33.
49. Rassool FV, Le Beau MM, Neilly ME, van Melle E, Espinoza R 3rd, McKeithan TW. Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA. Am J Hum Genet 1992;50:1243-51.